Bradykinin signal transduction in fibroblasts.
Burch
R M
RM
Nova Pharmaceutical Corporation, Baltimore, MD 21224.
D016475:3T3 Cells; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology*; D004075:Diglycerides / Q000378:metabolism; D015232:Dinoprostone / Q000378:metabolism; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D007700:Kinetics; D051379:Mice; D008807:Mice, Inbred BALB C; D008954:Models, Biological; D010741:Phospholipases A / Q000378:metabolism; D018002:Receptors, Bradykinin; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D013917:Thrombin / Q000494:pharmacology; D010738:Type C Phospholipases / Q000378:metabolism
D004075:Diglycerides; D018002:Receptors, Bradykinin; D017981:Receptors, Neurotransmitter; D010741:Phospholipases A; D010738:Type C Phospholipases; D013917:Thrombin; D015232:Dinoprostone; D001920:Bradykinin